Skip to main content
SpringerLink
Log in

Iron in Central Nervous System Disorders

  • Conference proceedings
  • © 1993

Overview

Editors:
  1. Peter Riederer

    1. Department of Psychiatry, University of Würzburg, Federal Republic of Germany

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

  2. M. B. H. Youdim

    1. Department of Pharmacology, Faculty of Medicine, Technion, Haifa, Israel

    View editor publications

    You can also search for this editor in PubMed   Google Scholar

Part of the book series: Key Topics in Brain Research (KEYTOPICS)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Log in via an institution
eBook USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (15 papers)

  1. Front Matter

    Pages I-VII
    Download chapter PDF

  2. Cellular and regional maintenance of iron homeostasis in the brain: normal and diseased states

    • J. R. Connor
    Pages 1-18

  3. Iron deposits in brain disorders

    • K. Jellinger, E. Kienzl
    Pages 19-36

  4. Brain iron and schizophrenia

    • K. W. Lange, J. Kornhuber, P. Kruzik, W.-D. Rausch, E. Gabriel, K. Jellinger et al.
    Pages 37-43

  5. Some reflections on iron dependent free radical damage in the central nervous system

    • M. E. Götz, A. Dirr, W. Gsell, R. Burger, A. Freyberger, P. Riederer
    Pages 45-54

  6. Iron regulation of dopaminergic transmission: relevance to movement disorders

    • D. Ben-Shachar, A. Tovi, M. B. H. Youdim
    Pages 55-66

  7. Dopaminergic cell death in Parkinson’s disease: a role of iron?

    • F. Javoy-Agid, B. Faucheux
    Pages 67-77

  8. Iron and neurotoxin intoxication: comparative in vitro and in vivo studies

    • W. Wesemann, St. Blaschke, H.-W. Clement, Chr. Grote, N. Weiner, W. Kolasiewicz et al.
    Pages 79-86

  9. Intranigral iron infusion in rats: A progressive model for excess nigral iron levels in Parkinson’s disease?

    • G. W. Arendash, C. W. Olanow, G. J. Sengstock
    Pages 87-101

  10. Iron storage and transport markers in Parkinson’s disease and MPTP-treated mice

    • D. C. Mash, J. Singer, J. Pablo, M. Basile, J. Bruce, W. J. Weiner
    Pages 103-116

  11. Pathogenesis of Parkinson’s disease: iron and mitochondrial DNA deletion

    • Y. Mizuno, H. Mochizuki, K. Nishi, S.-i. Ikebe, N. Hattori, Y. Hattori-Nakagawa
    Pages 117-135

  12. Consequences of intrastriatally administrated FeCl3 and 6-OHDA without and after transient cerebral oligemia on behaviour and navigation

    • C. Heim, W. Kolasiewicz, T. Jaros, K.-H. Sontag
    Pages 137-153

  13. Cytokine induced synthesis of nitric oxide from L-arginine: a cytotoxic mechanism that targets intracellular iron

    • J. B. Hibbs Jr.
    Pages 155-171

  14. Lazaroids: potent inhibitors of iron-dependent lipid peroxidation for neurodegenerative disorders

    • E. D. Hall, J. M. McCall
    Pages 173-188

  15. The treatment of iron overload — psychiatric implications

    • M. Struck, P. Waldmeier, V. Berdoukas
    Pages 189-196

  16. Iron therapy: Pros and Cons

    • G. Stern
    Pages 197-202

  17. Back Matter

    Pages 203-208
    Download chapter PDF
Back to top

Keywords

About this book

The role of the metals copper, zinc, magnesium, lead, manganese, mercury, lithium and aluminium in neuropsychiatric disease are well known and has been discussed on several occasions. Yet little attention has been paid to iron, the most abundant transitional metal in the body and the earth's crust. Iron plays a major role as a cofactor of numerous metabolic enzymes, it is important for DNA and protein synthesis, and has a crucial role in the oxygen carrying capacity of haemoglobin. Some of the most devastating diseases of systemic organs are associated with abnormal iron metabolism. Yet only very recently its role in the central nervous system has been considered. Thus nutritional iron defi­ ciency and iron overload afflict some 500-600 million people. It is also well recognized that too little or too much iron can produce profound effects on the metabolic state of the cell, and therefore the regulation of iron uptake and disposition is tightly relegated by the cell. Its transport into the cell and storage are handled by transferrin, ferritin and haemo­ siderin. Nowhere are these processes so well recognized as in the case of brain iron metabolism. Iron does not have ready access to the adult brain as it does to other tissues, since it does not cross the blood brain barrier (BBB). All the iron present in brain is deposited before the closure of BBB at an early age where it is sequestered and conserved. Therefore its turnover is extremely slow.

Editors and Affiliations

  • Department of Psychiatry, University of Würzburg, Federal Republic of Germany

    Peter Riederer

  • Department of Pharmacology, Faculty of Medicine, Technion, Haifa, Israel

    M. B. H. Youdim

Bibliographic Information

  • Book Title: Iron in Central Nervous System Disorders

  • Editors: Peter Riederer, M. B. H. Youdim

  • Series Title: Key Topics in Brain Research

  • DOI: https://doi.org/10.1007/978-3-7091-9322-8

  • Publisher: Springer Vienna

  • eBook Packages: Springer Book Archive

  • Copyright Information: Springer-Verlag/Wien 1993

  • Softcover ISBN: 978-3-211-82520-4Published: 30 December 1993

  • eBook ISBN: 978-3-7091-9322-8Published: 06 December 2012

  • Series ISSN: 0934-1420

  • Edition Number: 1

  • Number of Pages: VII, 205

  • Topics: Neurology, Neurosciences, Pharmacology/Toxicology, Animal Physiology

Publish with us

Policies and ethics

Back to top

Search

Navigation